Tissium
Updated: June 25, 2026
Christophe Bancel - Co-Founder, CEO
Country: France | Funding: $278M (+)
Founded: 2013
Website: https://tissium.com/
Tissium develops fully biosynthetic programmable polymers designed for atraumatic tissue repair and reconstruction. The company's portfolio includes one commercial product and six products in development in three areas: sutureless nerve repair, hernia repair, and cardiovascular sealants. The company's flagship product, COAPTIUM CONNECT, is designed for sutureless peripheral nerve repair. It is indicated for sutureless repair of unconnected peripheral nerve injuries where a gap of 1 centimeter or less exists or can be closed by flexing the limb. It allows surgeons to reconnect severed nerve ends without placing tiny sutures through the nerve.
Founded: 2013
Website: https://tissium.com/
Tissium develops fully biosynthetic programmable polymers designed for atraumatic tissue repair and reconstruction. The company's portfolio includes one commercial product and six products in development in three areas: sutureless nerve repair, hernia repair, and cardiovascular sealants. The company's flagship product, COAPTIUM CONNECT, is designed for sutureless peripheral nerve repair. It is indicated for sutureless repair of unconnected peripheral nerve injuries where a gap of 1 centimeter or less exists or can be closed by flexing the limb. It allows surgeons to reconnect severed nerve ends without placing tiny sutures through the nerve.
